Jiangsu Genscend Biopharmaceutical Co., Ltd
2 clinical trials · Sponsor
◉ Watch Jiangsu Genscend Biopharmaceutical Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection (NCT07411755) | Jiangsu Genscend Biopharmaceutical Co., Ltd | 2026-03-05 |
| A Phase III Study of GS101 Injection to Dupixent® (NCT07386743) | Jiangsu Genscend Biopharmaceutical Co., Ltd | 2026-02-01 |
Track Jiangsu Genscend Biopharmaceutical Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.